CRINETICS PHARMACEUTICALS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87875067
Serial Number
87875067
Registration Number
6603347
Word Mark
CRINETICS PHARMACEUTICALS
Status
700 - Registered
Status Date
2021-12-28
Filing Date
2018-04-12
Registration Number
6603347
Registration Date
2021-12-28
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260121, 260131, 261701, 261704, 261705, 261706 - Circles that are totally or partially shaded. Five or more circles. Straight line(s), band(s) or bar(s). Vertical line(s), band(s) or bar(s). Horizontal line(s), band(s) or bar(s). Diagonal line(s), band(s) or bar(s).
Published for Opposition Date
2018-09-18
Attorney Name
Chelsea E. Carbone
Law Office Assigned Location Code
M40
Employee Name
KEELEY, ALISON REBECCA
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMACEUTICALS"
Description of Mark
The mark consists of the word "CRINETICS" above the word "PHARMACEUTICALS" with a dot and line spirograph design in the shape of a half circle starting above the letter "I" in "CRINETICS" and wrapping around the first letter "C" in "CRINETICS".
Goods and Services
Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to treat or prevent dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to target neuropeptide receptors; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain
Goods and Services
Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-04-21
Primary Code
042
First Use Anywhere Date
2021-05-12
First Use In Commerce Date
2021-05-12
Current Trademark Owners
Party Name
Crinetics Pharmaceuticals, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Crinetics Pharmaceuticals, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Crinetics Pharmaceuticals, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Crinetics Pharmaceuticals, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Chelsea E. Carbone
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-04-16NEW APPLICATION ENTERED IN TRAM
2018-04-21NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-04-24NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-07-31ASSIGNED TO EXAMINER
2018-08-06EXAMINERS AMENDMENT -WRITTEN
2018-08-06EXAMINERS AMENDMENT E-MAILED
2018-08-06NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-08-06EXAMINER'S AMENDMENT ENTERED
2018-08-06APPROVED FOR PUB - PRINCIPAL REGISTER
2018-08-16ASSIGNED TO LIE
2018-08-29NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-09-18PUBLISHED FOR OPPOSITION
2018-09-18OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-11-13NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-04-17TEAS CHANGE OF OWNER ADDRESS RECEIVED
2019-04-17APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2019-04-17TEAS EXTENSION RECEIVED
2019-04-17EXTENSION 1 FILED
2019-04-17EXTENSION 1 GRANTED
2019-04-19NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-10-21TEAS EXTENSION RECEIVED
2019-10-21EXTENSION 2 FILED
2019-10-21EXTENSION 2 GRANTED
2019-10-23NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-04-24TEAS EXTENSION RECEIVED
2020-04-24EXTENSION 3 FILED
2020-04-24EXTENSION 3 GRANTED
2020-04-28NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-10-28TEAS EXTENSION RECEIVED
2020-10-28EXTENSION 4 FILED
2020-10-28EXTENSION 4 GRANTED
2020-10-30NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-04-29TEAS EXTENSION RECEIVED
2021-05-07CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-04-29EXTENSION 5 FILED
2021-05-07EXTENSION 5 GRANTED
2021-05-08NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-10-29TEAS STATEMENT OF USE RECEIVED
2021-10-29USE AMENDMENT FILED
2021-11-02STATEMENT OF USE PROCESSING COMPLETE
2021-11-19ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2021-11-20NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2021-12-28REGISTERED-PRINCIPAL REGISTER